Market revenue in 2021 | USD 414.8 million |
Market revenue in 2030 | USD 751.1 million |
Growth rate | 6.8% (CAGR from 2021 to 2030) |
Largest segment | Industrial enzymes |
Fastest growing segment | Specialty Enzymes |
Historical data | 2018 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Industrial Enzymes, Specialty Enzymes |
Key market players worldwide | BASF, Novonesis AS ADR, DuPont de Nemours Inc, DSM, Novus Holdings Ltd, Associated British Foods PLC, Advanced Enzymes, Bluestar Adisseo Co., Chr. Hansen, Lesaffre |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to enzymes market will help companies and investors design strategic landscapes.
Industrial enzymes was the largest segment with a revenue share of 56.75% in 2021. Horizon Databook has segmented the UK enzymes market based on industrial enzymes, specialty enzymes covering the revenue growth of each sub-segment from 2018 to 2030.
Food & beverages is one of the largest manufacturing sectors in the UK. Increasing population coupled with growing health awareness among consumers is expected to drive the utilization of enzymes in food & beverages.
According to the European Commission, aging population in the region is anticipated to grow substantially. Furthermore, the growing requirement for nutraceutical products due to the rising aging population in the country is also projected to spur the product demand over the forecast period.
The expansion of the above-mentioned companies is expected to stimulate the demand for enzymes in wastewater treatment. In addition, increasing spending and expansion by major pharmaceutical companies, including AstraZeneca plc, Shire Pharmaceuticals Limited UK, Hoffmann-La Roche Ltd, and Pfizer Inc., is likely to augment the demand for enzymes in the coming years.
Horizon Databook provides a detailed overview of country-level data and insights on the UK enzymes market , including forecasts for subscribers. This country databook contains high-level insights into UK enzymes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account